27 results
424B5
z22ndn8n087j9nmgr
20 Sep 19
Prospectus supplement for primary offering
4:43pm
8-K
EX-2.1
bci3wmxu
19 Jul 19
Interpace Diagnostics Acquires Cancer Genetics’ Biopharma Services Business Supported by Investment from Ampersand Capital Partners
5:03pm
8-K
EX-1.1
vowuucjd gsu
28 Jan 19
Interpace Diagnostics Announces Proposed Public Offering of Common Stock
9:40pm
424B5
ieicmkpbvrz1ly6v75
28 Jan 19
Prospectus supplement for primary offering
5:29pm